NEW YORK, Jan 29 (LSN) – Lawrence Lader, director of Abortion Rights Mobilization, which oversees manufacture and distribution of the abortion drug mifepristone (RU-486), complained to the media this week that access to RU-486 is restricted due to lack of producers and distributors. “Every major drug company turned it down. Big-name people won’t touch it,” said Lader. His small New York pro-abortion group arranged for surreptitious production of 10,000 doses of RU486 and is providing it to 11 doctors around the country as part of a research project.  Bernard Gore, a San Francisco-Oakland abortionist who is taking part in the study has administered the drug to hundreds of women resulting in the killing of about 300 babies. “It is a clinical study that is testing a chemical to destroy a child in the womb. This should be astounding to people and society that we are willing to test a pill to kill children,” said Judy Brown of the group American Life League of Stafford, Va.  The pro-abortion Population Council gained the US patent rights to the drug in 1996. The group chose lawyer and businessman Joseph D. Pike to arrange the drug’s manufacture and distribution. However,  Pike was found to have resigned from the North Carolina Bar due to criminal charges of forgery. As a result, the council had to go to court to get Pike to sell his controlling interest in the project,  which was subsequently sold to other investors.  Next, a privately held company called Advances/Neogen was created to handle manufacture and distribution of RU486. However, the chief executive of Advances/Neogen recently stepped down, and a new leader is yet to be named. In the mean time, a Hungarian company, which was chosen by Advances/Neogen to manufacture the drug, has pulled out of the project without explanation.


Commenting Guidelines
LifeSiteNews welcomes thoughtful, respectful comments that add useful information or insights. Demeaning, hostile or propagandistic comments, and streams not related to the storyline, will be removed.

LSN commenting is not for frequent personal blogging, on-going debates or theological or other disputes between commenters.

Multiple comments from one person under a story are discouraged (suggested maximum of three). Capitalized sentences or comments will be removed (Internet shouting).

LifeSiteNews gives priority to pro-life, pro-family commenters and reserves the right to edit or remove comments.

Comments under LifeSiteNews stories do not necessarily represent the views of LifeSiteNews.